Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial

被引:53
作者
von Blanckenburg, Pia [1 ]
Schuricht, Franziska [1 ]
Albert, Ute-Susann [2 ]
Rief, Winfried [1 ]
Nestoriuc, Yvonne [3 ]
机构
[1] Univ Marburg, Dept Clin Psychol & Psychotherapy, D-35032 Marburg, Germany
[2] Univ Marburg, Breast Canc Ctr, Dept Gynecol Gynecol Endocrinol & Oncol, D-35032 Marburg, Germany
[3] Univ Hamburg, Dept Clin Psychol, Hamburg, Germany
关键词
Nocebo; Side effects; Prevention; Breast cancer; Endocrine therapy; RCT; ADJUVANT HORMONAL-THERAPY; EUROPEAN-ORGANIZATION; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; COMBINATION TRIAL; CLINICAL-TRIALS; ATAC ARIMIDEX; SHORT-FORM; ADHERENCE; QUESTIONNAIRE;
D O I
10.1186/1471-2407-13-426
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Adjuvant endocrine therapy can improve disease-free survival and time before recurrence in breast cancer patients. However, it is associated with considerable side effects that negatively affect patients' quality of life and cause non-adherence. The recently demonstrated effect of individual expectations on side-effect development (nocebo effect) suggests that psychological factors play a role in the prevention of side effects. The aim of this study is to evaluate cognitive-behavioral side-effect prevention training (SEPT) for breast cancer patients. This article describes the study protocol and applied research methods. Methods/Design: In a randomized controlled trial, 184 female breast cancer patients are assigned to receive either SEPT, standard medical care or a manualized supportive therapy at the start of adjuvant endocrine treatment. SEPT consists of three sessions of cognitive-behavioral training including psychoeducation to provide a realistic view of endocrine therapy, imagination-training to integrate positive aspects of medication into daily life, and side-effect management to enhance expectations about coping ability. Side effects three months after the start of endocrine therapy serve as primary outcomes. Secondary outcomes include quality of life, coping ability and patients' medication adherence. Patients' expectations (i.e., expectations about side effects, coping ability, treatment and illness) are analyzed as mediators. Discussion: The optimization of expectations might be a potential pathway in health care to improve patients' quality of life during long-term medication intake. The results will provide implications for a possible integration of evidence-based prevention training into clinical practice.
引用
收藏
页数:10
相关论文
共 62 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1
  • [3] The Impact of Breast Care Nurses on Patients' Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy
    Albert, Ute-Susann
    Zemlin, Cosima
    Hadji, Peymann
    Ziller, Volker
    Kuhler, Barbara
    Frank-Hahn, Birgit
    Wagner, Uwe
    Kalder, Matthias
    [J]. BREAST CARE, 2011, 6 (03) : 221 - 226
  • [4] Evaluation of screening instruments for depression and anxiety in breast cancer survivors
    Alexander, Susanna
    Palmer, Clare
    Stone, Patrick C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (02) : 573 - 578
  • [5] [Anonymous], VERHALTENSTHERAPI S1
  • [6] [Anonymous], 2009, GEN ASSESSMENT SIDE
  • [7] [Anonymous], PSYCHOTHERAPIE
  • [8] [Anonymous], J CANC RES CLIN O S1
  • [9] [Anonymous], PSYCHOL FACTORS MARI
  • [10] Nonspecific medication side effects and the nocebo phenomenon
    Barsky, AJ
    Saintfort, R
    Rogers, MP
    Borus, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05): : 622 - 627